Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0CJ7L
|
|||
| Former ID |
DNC009839
|
|||
| Drug Name |
N-hydroxy-8-(naphthalen-2-yl)oct-7-enamide
|
|||
| Synonyms |
CHEMBL451182; N-hydroxy-8-(naphthalen-2-yl)oct-7-enamide; SCHEMBL3382916; SCHEMBL3382922; PGGPUSMJSOKMEA-XBXARRHUSA-N; ZINC13474418; BDBM50114829; (E)-N-Hydroxy-8-(2-naphthyl)-7-octenamide; 8-Naphthalen-2-yl-oct-7-enoic acid hydroxyamide; (E)-8-Naphthalen-2-yl-oct-7-enoic acid hydroxyamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H21NO2
|
|||
| Canonical SMILES |
C1=CC=C2C=C(C=CC2=C1)C=CCCCCCC(=O)NO
|
|||
| InChI |
1S/C18H21NO2/c20-18(19-21)11-5-3-1-2-4-8-15-12-13-16-9-6-7-10-17(16)14-15/h4,6-10,12-14,21H,1-3,5,11H2,(H,19,20)/b8-4+
|
|||
| InChIKey |
PGGPUSMJSOKMEA-XBXARRHUSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. Eur J Med Chem. 2009 Jul;44(7):2868-76. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.